Feedback / Questions
AlloStem (CELZ-201) - Creative Medical Technology
https://www.globenewswire.com/news-release/2025/03/20/3046141/0/en/Creative-Medical-Technology-Holdings-Secures-FDA-Clearance-for-Expanded-Dose-Escalation-in-the-Clinical-Trial-of-CELZ-201-DDT-for-Chronic-Lower-Back-Pain.html
Mar 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next